TP53 and ovarian cancer: Also, a few dysfunctional signaling pathways, e.g., MYC, TP53, PI3K/RAS, were be identified in ovarian cancer by mapping multi-omics data, e.g., differentially expressed genes, mutations, copy number variation, and methylation data, to the curated signaling pathways [8].